Mom and Baby Beat 1-in-a-Million Odds to Survive the ‘Rarest of Pregnancies’

This photo provided by the family shows, from left, Kaila, Suze, Ryu and Andrew Lopez at Cedars-Sinai hospital in Los Angeles in August 2025 – family photo

A Los Angeles woman recently celebrated the first Christmas with her baby boy, Ryu, born to truly remarkable circumstances.

Ryu developed outside his mother’s womb, and remained hidden for months behind an ovarian cyst that grew to be the size of a basketball. It was so unbelievable, the surgical/OBGYN team that delivered Ryu documented it for a case study in a medical journal.

The manner in which Ryu came into being represents a circumstance that’s “far, far less than 1 in a million,” said Dr. John Ozimek, medical director of labor and delivery at Cedars-Sinai in Los Angeles, where Ryu was born. “I mean, this is really insane.”

Now 41, Suze Lopez has always had an irregular cycle, so missed periods—even consecutive ones—are a normal occurrence. It was almost 20 years ago that she was diagnoses with a pair of ovarian cysts, one of which was removed immediately, and one of which was not.

So in early 2025 when Lopez noted her abdomen swelling, her first thought was the cyst. She never felt kicking, and never had morning sickness—and indeed her instinct was at least partly correct.

The pressure and pain in her abdomen grew as days passed, and she was certain that, even if it risked her ability to conceive again, it was time to remove the other cyst which unbeknownst to her had grown to weigh a mind-boggling 22 pounds.

She needed a CT scan to prepare for surgery, which required a pregnancy test for the radiation, and to her utter surprise the test came back positive. Lopez was delighted, but the pain and discomfort grew and soon she had to be hospitalized at Cedars-Sinai where her medical team found a near fully-developed fetus in an amniotic sack lodged against her pelvis.

The term for where the fetus develops is “implants” and the term for a fetus that implants outside of the womb is an “ectopic pregnancy.” Almost all of these go on to rupture and hemorrhage. As such, fetal mortality can be as high as 90% in such cases and birth defects are seen in about 1 in 5 surviving babies, SF Gate reports.

However, because fetal Ryu implanted against the pelvic wall and not against the liver, it was far more manageable, and the reason why Lopez didn’t have more pain earlier.

Lopez and her boy beat the odds, despite a mammoth surgical procedure that both delivered Ryu at 8 pounds and removed the ovarian cyst—together weighing as much as an adult bobcat. During the procedure, Lopez lost half her blood, and had to be continually given transfusions.

“The whole time, I might have seemed calm on the outside, but I was doing nothing but praying on the inside,” Andrew Lopez, Suze’s husband, told SF Gate. “It was just something that scared me half to death, knowing that at any point I could lose my wife or my child.”Instead, they both survived without any maleffects. Ryu “completes” their family, said his mother, and recently celebrated his first Christmas alongside his older sister Kaila. Mom and Baby Beat 1-in-a-Million Odds to Survive the ‘Rarest of Pregnancies

Read More........→January 10, 2026

A Rare Cancer-Fighting Plant Compound has Finally Been Decoded

Anti-cancer plant enzyme uncovered by Tuan-Anh Nguyen and Dr Thu-Thuy Dang – UBC Okanagan

Canadian researchers have figured out how plants make a rare natural substance—mitraphylline—with its potential for fighting cancer and becoming a sustainable new medicine.

Mitraphylline is part of a small and unusual family of plant alkaloids, molecules that are defined by their distinctive twisted ring shapes, which help give them powerful anti-tumor and anti-inflammatory effects.

For years, scientists knew these compounds were valuable but had little understanding of how plants actually assembled them at the molecular level.

In solving a long standing biological mystery, progress came in 2023, when a research team led by Dr. Thu-Thuy Dang at the University of British Columbia-Okanagan identified the first known plant enzyme capable of creating the signature ‘spiro’ shape found in these molecules.

Building on that discovery, doctoral student Tuan-Anh Nguyen led new work to pinpoint two key enzymes involved in making mitraphylline—one enzyme that arranges the molecule into the correct three dimensional structure, and another that twists it into its final form.

“This is similar to finding the missing links in an assembly line,” says Dr. Dang, the university’s Research Chair in Natural Products Biotechnology. “It answers a long-standing question about how nature builds these complex molecules and gives us a new way to replicate that process.”

Red vein kratom leaves by Jade at Thehealingeast – CC BY-SA 4.0

Many promising natural compounds exist only in extremely small quantities within plants, making them expensive or impractical to produce using traditional laboratory methods. Mitraphylline is a prime example. It appears only in trace amounts in tropical coffee trees such as Mitragyna (kratom) and Uncaria (cat’s claw).

By identifying the enzymes that construct and shape mitraphylline, scientists now have a clear guide for recreating this process in more sustainable and scalable ways.

Toward Greener Drug Production

“With this discovery, we have a green chemistry approach to accessing compounds with enormous pharmaceutical value,” says Nguyen. “This is a result of UBC Okanagan’s research environment, where students and faculty work closely to solve problems with global reach.”

“Plants are fantastic natural chemists,” Dr. Dang said.

“Our next steps will focus on adapting their molecular tools to create a wider range of therapeutic compounds.”“Being part of the team that uncovered the enzymes behind spirooxindole compounds has been amazing,” added Nguyen, whose team collaborated with researchers at the University of Florida. A Rare Cancer-Fighting Plant Compound has Finally Been Decoded

Read More........→January 08, 2026